Prescription pattern and adverse drug reactions in respiratory tract infection patients: A prospective study
Bioinformation · 31.07.2026 · 22 (7) · 4359-4363
DOI: 10.6026/973206300224359 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformation, online erschienen am 31.07.2026. Verfasst von Aditya Bharatkumar Pandya.
Abstract (Originalsprache)
Respiratory tract infections (RTIs) are a major cause of hospitalization and antimicrobial use, requiring evaluation of prescribing practices and adverse drug reactions (ADRs). A prospective observational study of 100 hospitalized RTI patients was conducted between September 2024 and March 2026 to evaluate prescribing patterns, WHO prescribing indicators, supportive medications and ADRs. Lower respiratory tract infection was the most common diagnosis (36%); ceftriaxone (29%) was the most frequently prescribed antibiotic, followed by amoxicillin (25%) and azithromycin (24%); the average number of drugs per prescription was 4.25, with 60.7% prescribed by generic name and 67.52% from the National List of Essential Medicines. Most patients recovered (85%) and only five antibiotic-related ADRs were reported. Thus, data shows that prescribing practices were largely rational; however, polypharmacy and empirical antibiotic use highlighted the need for strengthened antimicrobial stewardship and pharmacovigilance.
Zitieren
APA
Pandya, A. B. (2026). Prescription pattern and adverse drug reactions in respiratory tract infection patients: A prospective study. Bioinformation, 22(7), 4359-4363. https://doi.org/10.6026/973206300224359
Vancouver
Pandya AB. Prescription pattern and adverse drug reactions in respiratory tract infection patients: A prospective study. Bioinformation. 2026;22(7):4359-4363. doi:10.6026/973206300224359
BibTeX
@article{Pandya2026,
author = {Pandya, Aditya Bharatkumar},
title = {Prescription pattern and adverse drug reactions in respiratory tract infection patients: A prospective study},
journal = {Bioinformation},
year = {2026},
volume = {22},
number = {7},
pages = {4359--4363},
doi = {10.6026/973206300224359}
}
EUVIMED